All Pathways
Pulmonary MedicineEmergency

Acute Asthma Exacerbation Management (GINA 2025)

Acute Asthma Exacerbation Management (GINA 2025): Acute Asthma Exacerbation → Assess Severity → ⚠️ Life-Threatening → ICU/HDU Admission.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Acute Asthma Exacerbation

    Patient presents with acute worsening of asthma symptoms (wheeze, SOB, cough, chest tightness)

    1. Decision

      Assess Severity

      Evaluate talking, alertness, respiratory rate, accessory muscle use, pulse, SpO2, PEF

      • Mild-Moderate: Talks in phrases, prefers sitting, RR increased, no accessory muscles, HR 100-120, SpO2 90-95%
      • Severe: Talks in words, sits hunched forward, RR >30, accessory muscles, HR >120, SpO2 <90%
      • Life-threatening: Drowsy/confused, silent chest, bradycardia, SpO2 <90%
      1. Warning

        ⚠️ Life-Threatening

        Immediate ICU/resuscitation - prepare for intubation

        • Silent chest, cyanosis, poor respiratory effort
        • Bradycardia, hypotension, exhaustion/confusion
        • PEF <25% predicted or unmeasurable
        • Call for senior/ICU support immediately
        1. Outcome

          ICU/HDU Admission

          For severe/life-threatening asthma

          • Requiring ventilatory support
          • Deteriorating PEF/symptoms despite treatment
          • Hypercapnia or severe hypoxia
          • Exhaustion, drowsiness, confusion
      2. Action

        Initial Treatment (First Hour)

        Start SABA + controlled oxygen + consider corticosteroids

        • SABA: Salbutamol 4-10 puffs via pMDI+spacer every 20 min x3, OR 2.5-5mg nebulized
        • Oxygen: Target SpO2 93-95% (94-98% in children)
        • Corticosteroids: Prednisolone 40-50mg PO or Hydrocortisone 100mg IV
        • If severe: Add ipratropium 500mcg nebulized every 20 min x3
        1. Decision

          Reassess at 1 Hour

          Evaluate response to treatment

          • Good response: Symptoms improved, PEF >60-80% predicted, SpO2 >94%
          • Incomplete response: Some improvement but not resolved
          • Poor response: No improvement or worsening
          1. Action

            Good Response

            Continue monitoring, prepare for discharge

            • Observe for 1 hour after last nebulizer
            • Continue oral prednisolone 40-50mg daily x 5-7 days
            • Review inhaler technique
            • Provide written asthma action plan
            1. Outcome

              Discharge with Action Plan

              Criteria met for safe discharge

              • PEF >75% predicted or personal best
              • SpO2 >94% on room air
              • Adequate inhaler technique demonstrated
              • Oral corticosteroids for 5-7 days
              • Follow-up appointment within 2-7 days
          2. Action

            Incomplete Response

            Intensify treatment

            • Continue SABA every 60 min
            • Add ipratropium if not already given
            • Consider IV magnesium sulfate 2g over 20 min (if severe)
            • Continue monitoring, reassess frequently
            1. Action

              IV Magnesium Sulfate

              For severe exacerbation not responding to initial treatment

              • Dose: 1.2-2g IV over 20 minutes
              • Single dose only
              • Monitor BP during infusion
              • Not routinely recommended for mild-moderate
              1. Outcome

                Admit to Hospital

                For ongoing treatment and monitoring

                • SpO2 <92% on room air
                • PEF <50% predicted after treatment
                • Unable to maintain improvement
                • High-risk features present
                • Social/psychological factors
          3. Action

            Poor Response/Worsening

            Escalate care

            • IV magnesium sulfate 2g over 20 min if not given
            • Consider IV salbutamol 250mcg slowly
            • Urgent ICU referral if deteriorating
            • Prepare for possible intubation

Guideline Source

Global Initiative for Asthma (GINA) 2025 Strategy Report

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address life-threatening asthma requiring immediate intubation
  • Pediatric dosing differs - refer to pediatric guidelines for children <6 years
  • Does not cover asthma in pregnancy (special considerations apply)
  • Drug dosing may need adjustment for severe renal/hepatic impairment

Contraindicated Populations

neonates

Applicable Regions

Global

Global: GINA guidelines are internationally recognized and adaptable to local resources

Version 1Next review: 2027-05-01

Frequently Asked Questions

What is the Acute Asthma Exacerbation Management (GINA 2025)?

The Acute Asthma Exacerbation Management (GINA 2025) is a emergency clinical algorithm for Pulmonary Medicine. It provides a structured decision tree to guide clinical decision-making, based on Global Initiative for Asthma (GINA) 2025 Strategy Report.

What guideline is the Acute Asthma Exacerbation Management (GINA 2025) based on?

This algorithm is based on Global Initiative for Asthma (GINA) 2025 Strategy Report (DOI: ginasthma.org/2025-gina-strategy-report).

What are the limitations of the Acute Asthma Exacerbation Management (GINA 2025)?

Known limitations include: Does not address life-threatening asthma requiring immediate intubation; Pediatric dosing differs - refer to pediatric guidelines for children <6 years; Does not cover asthma in pregnancy (special considerations apply); Drug dosing may need adjustment for severe renal/hepatic impairment. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Asthma Exacerbation Management (GINA 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free